Stocks and Investing Stocks and Investing
Tue, September 24, 2024

Terence Flynn Upgraded (BNTX) to Buy and Increased Target to $145 on, Sep 24th, 2024


Published on 2024-10-28 14:25:28 - WOPRAI, Terence Flynn
  Print publication without navigation


Terence Flynn of Morgan Stanley, Upgraded "BioNTech SE" (BNTX) to Buy and Increased Target from $93 to $145 on, Sep 24th, 2024.

Terence has made no other calls on BNTX in the last 4 months.



There are 7 other peers that have a rating on BNTX. Out of the 7 peers that are also analyzing BNTX, 3 agree with Terence's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Eliana Merle of "UBS" Maintained at Hold with Increased Target to $131 on, Wednesday, September 18th, 2024
  • Jessica Fye of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $125 on, Monday, September 16th, 2024
  • Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024


These are the ratings of the 4 analyists that currently disagree with Terence


  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $150 on, Thursday, September 19th, 2024
  • Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $150 on, Tuesday, September 17th, 2024
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $113 on, Monday, September 16th, 2024
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $150 on, Monday, September 16th, 2024
Contributing Sources